FMCT-pc2.

We are funding a study that aims to optimize an in vitro experimental assay that is capable of testing individual small molecules or combinations of small molecule’s effect on various epigenetic clocks. The goal of this project is to develop a system that is capable of the rapid screening of antiaging interventions. In this way, we hope to speed up the development of viable antiaging therapies. It is our strong belief that these interventions not only have potential to treat cancer once it has developed, but also as an intervention to prevent cancers from developing in the first place.

onenine

Preclinical Studies

07/10/2025

Other Projects of Interest

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

This is a Phase 2, randomized two-armed, multi-site study of 170 patients with newly diagnosed glioblastoma multiforme. Patients will be

Clinical Trials

FMCT-ct1.

We are in the preliminary planning to fund a two-armed, phase 2 clinical trial testing the adjunctive efficacy of the

Preclinical Studies

FMCT-pc3.

We are funding research to test the preclinical efficacy of a special formulation of mebendazole designed to make the active